# ImageneBio (IMA) — Earnings

IMA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ima/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$2.70 |
| EPS estimate | −$0.33 |
| EPS surprise | −716.67% |
| Revenue surprise | +0.00% |
| Revenue | −$500,000.00 |
| Revenue estimate | $0.00 |
| Reported | Jul 24, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1835579/000095017025098414/ikna-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Jul 24, 2025 | −$0.33 | −$2.70 | -716.67% | — | — |
| Q1 2025 | May 8, 2025 | −$1.97 | −$2.04 | -3.47% | — | — |
| Q4 2024 | Mar 6, 2025 | −$2.99 | −$2.40 | 19.66% | $875,000.00 | — |
| Q3 2024 | Nov 7, 2024 | −$3.06 | −$2.52 | 17.61% | — | — |
| Q2 2024 | Aug 8, 2024 | −$4.16 | −$3.36 | 19.19% | — | — |
| Q1 2024 | May 13, 2024 | −$4.77 | −$3.96 | 17.02% | $2.3M | — |
| Q4 2023 | Mar 12, 2024 | −$4.99 | −$4.92 | 1.49% | $2.4M | $658,000.00 |
| Q3 2023 | Nov 9, 2023 | −$5.17 | −$4.80 | 7.12% | $2.8M | $1.2M |
| Q2 2023 | Aug 10, 2023 | −$5.69 | −$5.28 | 7.15% | $3.9M | $2.0M |
| Q1 2023 | May 15, 2023 | −$5.60 | −$4.68 | 16.41% | $4.6M | $5.3M |
| Q4 2022 | Mar 14, 2023 | −$1.75 | −$4.68 | -167.35% | $6.0M | $5.5M |
| Q3 2022 | Nov 7, 2022 | −$5.92 | −$5.76 | 2.72% | $4.3M | $6.4M |
| Q2 2022 | Aug 11, 2022 | −$5.86 | −$6.84 | -16.76% | $3.9M | $382,000.00 |
| Q1 2022 | May 12, 2022 | −$5.02 | −$5.64 | -12.41% | $4.6M | $3.4M |
| Q4 2021 | Mar 17, 2022 | −$6.15 | $0.84 | 113.66% | $4.8M | $20.2M |
| Q3 2021 | Nov 10, 2021 | −$5.04 | −$4.80 | 4.76% | $4.1M | $3.7M |
| Q2 2021 | Aug 12, 2021 | −$4.29 | −$4.20 | 2.10% | $3.9M | $3.5M |
| Q1 2021 | May 13, 2021 | −$10.46 | −$30.24 | -189.24% | $4.0M | $3.5M |

## Frequently Asked Questions

### When did ImageneBio (IMA) last report earnings?

ImageneBio last reported on Jul 24, 2025, covering fiscal Q2 2025.

### Did IMA beat earnings estimates?

No. ImageneBio reported EPS of −$2.70 for Q2 2025 against a −$0.33 estimate — a 716.67% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).